Is International Journal of Biological Macromolecules a Good Journal? The Elsevier Biopolymer Workhorse

IJBM has a clear editorial line that many authors miss. The journal wants structure-function papers, not structure-only or function-only papers.

Papers editors want:

• Protein characterization with direct functional evidence (binding, activity, folding behavior)
• Polysaccharide structure elucidation connected to biological or physical properties
• Nucleic acid work where the macromolecular behavior drives the science
• Biopolymer modification studies that measure functional consequences, not just confirm the modification happened
• Interaction studies (protein-protein, protein-polysaccharide, biopolymer-drug) with mechanistic explanation

Papers that get desk-rejected:

• Gene or genome analysis without direct macromolecular structure-function evidence
• Application papers where the biopolymer is a passive ingredient (coatings, fillers, matrices)
• Characterization-only work that confirms structure but never explains function
• Clinical or biomedical studies where the macromolecule is not the active scientific core
• Papers below the molecular size floor (small molecules, peptides under ~2 kDa)

IJBM publishes over 2,000 papers per year. Some researchers see this as a warning sign, high-volume journals sometimes dilute quality. In IJBM's case, the volume reflects the enormous breadth of biopolymer research worldwide rather than low standards. The 25-30% acceptance rate is genuine. But the sheer volume means that individual papers can get less attention than they would in a smaller journal. If citation visibility matters more to you than journal prestige, consider whether a more specialized venue would put your paper in front of a more targeted readership.

Before submitting to IJBM, run this test: remove all application framing from your paper. Does the macromolecule itself remain scientifically interesting? If yes, IJBM is likely a good fit. If the paper becomes empty without the application context, the macromolecule isn't really the protagonist and another journal is the better choice.

A IJBM scope and readiness check can help assess whether the structure-function case is strong enough for IJBM before you submit.

Journal editorial capacity fluctuates. Submissions during major conference seasons face longer reviewer turnaround. End-of-year submissions may sit longer during holiday periods. New IF announcements (June each year) can temporarily increase submissions to journals whose IF rose.

For selective journals, the practical advice is: submit when the manuscript is ready, not when the calendar seems favorable. A paper that is scientifically complete and properly targeted will succeed regardless of timing. A paper with gaps will fail regardless of when you submit.

A IJBM submission readiness check evaluates fit independently of timing.